Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-002968
Filing Date
2017-01-09
Accepted
2017-01-09 17:08:30
Documents
1
Period of Report
2017-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3209
  Complete submission text file 0001209191-17-002968.txt   4582
Mailing Address C/O MEDAREX, INC 707 STATE ROAD PRINCETON NJ 08540
Business Address
PIEN HOWARD H (Reporting) CIK: 0001187152 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 17518516

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

EIN.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)